PDI, Inc. (PDII) Enters New $57M PCP Targeting Contract
Tweet
Share
E-mailGet Alerts PDII Hot Sheet
Join SI Premium – FREE
PDI, Inc. (Nasdaq: PDII) has signed a contract with a new customer to provide promotional services across PDI's multiple communications channels that will target primary care physicians. The contract is subject to FDA product approval. The contract is expected to generate total revenue to PDI of approximately $57 million over the life of the two-year agreement, with $10-$12 million to be recorded over the second half of 2012.
Under the agreement, PDI will provide an array of promotional services, including but not limited to dedicated sales teams, as well as teledetailing and digital communications through PDI's Group DCA division.
Under the agreement, PDI will provide an array of promotional services, including but not limited to dedicated sales teams, as well as teledetailing and digital communications through PDI's Group DCA division.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Revolution Medicines prices RASONQUE at $39,800 per month
- Alcon prices €500M senior notes due 2033
- FDA approves Revolution Medicines pancreatic cancer drug Rasonque
Create E-mail Alert Related Categories
Corporate NewsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
